Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.22 and traded as high as $0.25. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares.
Lexaria Bioscience Trading Down 10.7 %
The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.01 and a current ratio of 8.52. The stock has a 50-day moving average of $0.22.
Lexaria Bioscience Company Profile
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
Read More
- Five stocks we like better than Lexaria Bioscience
- What Is WallStreetBets and What Stocks Are They Targeting?
- The 3 Hottest Insiders Buys This Month
- Insider Buying Explained: What Investors Need to Know
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- Golden Cross Stocks: Pattern, Examples and Charts
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
